Supplemental Guarantor Information (Level 4 CF) (Details 2) (USD $) In Thousands, unless otherwise specified
|
3 Months Ended |
Jan. 31, 2013
|
Jan. 31, 2012
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
Net income (loss) |
$ 4,432 |
$ (2,786) |
Depreciation and amortization |
6,525 |
5,229 |
Stock-based compensation |
5,684 |
5,626 |
Income from unconsolidated entities |
(3,083) |
(6,687) |
Distributions of earnings from unconsolidated entities |
2,413 |
872 |
Income from distressed loans and foreclosed real estate |
(3,011) |
(4,138) |
Deferred tax provision (benefit) |
2,306 |
(1,246) |
Deferred tax valuation allowances |
(216) |
1,246 |
Inventory impairments and write-offs |
709 |
8,120 |
Change in fair value of mortgage loans receivable and derivative instruments |
554 |
346 |
Gain on marketable securities |
|
(39) |
Changes in operating assets and liabilities |
|
|
Increase in inventory |
(378,715) |
(108,468) |
Origination of mortgage loans |
(141,148) |
(120,662) |
Sale of mortgage loans |
176,830 |
146,895 |
Decrease (increase) in restricted cash |
13,519 |
(28,481) |
Increase (Decrease) in Other Operating Assets |
(8,256) |
11,781 |
Increase in customer deposits |
12,059 |
3,230 |
(Decrease) increase in accounts payable and accrued expenses |
1,302 |
(67,127) |
Increase (decrease) in income taxes payable |
2,274 |
(5,790) |
Net cash used in operating activities |
(305,822) |
(162,079) |
Cash flow from investing activities: |
|
|
Purchase of property and equipment - net |
(5,391) |
(3,392) |
Purchase of marketable securities |
(26,019) |
|
Sale and redemption of marketable securities |
38,775 |
88,217 |
Investment in and advances to unconsolidated entities |
(7,614) |
(71,784) |
Return of investments in unconsolidated entities |
17,311 |
15,333 |
Investment in distressed loans and foreclosed real estate |
(16,252) |
(26,410) |
Return of investments in distressed loans and foreclosed real estate |
3,015 |
3,702 |
Acquisition of a business |
|
(144,746) |
Net cash used in investing activities |
3,825 |
(139,080) |
Cash flow from financing activities: |
|
|
Proceeds from loans payable |
244,830 |
199,139 |
Principal payments of loans payable |
(299,862) |
(237,896) |
Redemption of senior notes |
(59,068) |
|
Proceeds from stock-based benefit plans |
6,108 |
9,334 |
Purchase of treasury stock |
(79) |
(64) |
Net cash used in financing activities |
(108,071) |
(29,487) |
Net decrease in cash and cash equivalents |
(410,068) |
(330,646) |
Cash and cash equivalents, beginning of period |
778,824 |
906,340 |
Cash and cash equivalents, end of period |
368,756 |
575,694 |
Toll Brothers Inc. [Member]
|
|
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
Net income (loss) |
4,432 |
(2,786) |
Depreciation and amortization |
6 |
|
Stock-based compensation |
5,684 |
5,626 |
Income from unconsolidated entities |
|
|
Distributions of earnings from unconsolidated entities |
|
|
Income from distressed loans and foreclosed real estate |
|
|
Deferred tax provision (benefit) |
2,306 |
(1,246) |
Deferred tax valuation allowances |
(216) |
1,246 |
Inventory impairments and write-offs |
|
|
Change in fair value of mortgage loans receivable and derivative instruments |
|
|
Gain on marketable securities |
|
|
Changes in operating assets and liabilities |
|
|
Increase in inventory |
|
|
Origination of mortgage loans |
|
|
Sale of mortgage loans |
|
|
Decrease (increase) in restricted cash |
13,208 |
(28,307) |
Increase (Decrease) in Other Operating Assets |
(30,512) |
22,096 |
Increase in customer deposits |
|
|
(Decrease) increase in accounts payable and accrued expenses |
(3,211) |
(109) |
Increase (decrease) in income taxes payable |
2,274 |
(5,790) |
Net cash used in operating activities |
(6,029) |
(9,270) |
Cash flow from investing activities: |
|
|
Purchase of property and equipment - net |
|
|
Purchase of marketable securities |
|
|
Sale and redemption of marketable securities |
|
|
Investment in and advances to unconsolidated entities |
|
|
Return of investments in unconsolidated entities |
|
|
Investment in distressed loans and foreclosed real estate |
|
|
Return of investments in distressed loans and foreclosed real estate |
|
|
Acquisition of a business |
|
|
Net cash used in investing activities |
0 |
0 |
Cash flow from financing activities: |
|
|
Proceeds from loans payable |
|
|
Principal payments of loans payable |
|
|
Redemption of senior notes |
|
|
Proceeds from stock-based benefit plans |
6,108 |
9,334 |
Purchase of treasury stock |
(79) |
(64) |
Net cash used in financing activities |
6,029 |
9,270 |
Net decrease in cash and cash equivalents |
0 |
0 |
Cash and cash equivalents, beginning of period |
|
0 |
Cash and cash equivalents, end of period |
0 |
0 |
Subsidiary Issuer [Member]
|
|
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
Net income (loss) |
(1,449) |
0 |
Depreciation and amortization |
3,570 |
794 |
Stock-based compensation |
|
|
Income from unconsolidated entities |
|
|
Distributions of earnings from unconsolidated entities |
|
|
Income from distressed loans and foreclosed real estate |
|
|
Deferred tax provision (benefit) |
|
|
Deferred tax valuation allowances |
|
|
Inventory impairments and write-offs |
|
|
Change in fair value of mortgage loans receivable and derivative instruments |
|
|
Gain on marketable securities |
|
|
Changes in operating assets and liabilities |
|
|
Increase in inventory |
|
|
Origination of mortgage loans |
|
|
Sale of mortgage loans |
|
|
Decrease (increase) in restricted cash |
|
|
Increase (Decrease) in Other Operating Assets |
46,897 |
(4,793) |
Increase in customer deposits |
|
|
(Decrease) increase in accounts payable and accrued expenses |
10,050 |
3,999 |
Increase (decrease) in income taxes payable |
|
|
Net cash used in operating activities |
59,068 |
0 |
Cash flow from investing activities: |
|
|
Purchase of property and equipment - net |
|
|
Purchase of marketable securities |
|
|
Sale and redemption of marketable securities |
|
|
Investment in and advances to unconsolidated entities |
|
|
Return of investments in unconsolidated entities |
|
|
Investment in distressed loans and foreclosed real estate |
|
|
Return of investments in distressed loans and foreclosed real estate |
|
|
Acquisition of a business |
|
|
Net cash used in investing activities |
0 |
0 |
Cash flow from financing activities: |
|
|
Proceeds from loans payable |
|
|
Principal payments of loans payable |
|
|
Redemption of senior notes |
(59,068) |
|
Proceeds from stock-based benefit plans |
|
|
Purchase of treasury stock |
|
|
Net cash used in financing activities |
(59,068) |
0 |
Net decrease in cash and cash equivalents |
0 |
0 |
Cash and cash equivalents, beginning of period |
|
|
Cash and cash equivalents, end of period |
0 |
0 |
Guarantor Subsidiaries [Member]
|
|
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
Net income (loss) |
5,072 |
(2,782) |
Depreciation and amortization |
5,139 |
4,419 |
Stock-based compensation |
|
|
Income from unconsolidated entities |
(1,117) |
(7,729) |
Distributions of earnings from unconsolidated entities |
690 |
872 |
Income from distressed loans and foreclosed real estate |
|
|
Deferred tax provision (benefit) |
|
|
Deferred tax valuation allowances |
|
|
Inventory impairments and write-offs |
740 |
8,120 |
Change in fair value of mortgage loans receivable and derivative instruments |
|
|
Gain on marketable securities |
|
(39) |
Changes in operating assets and liabilities |
|
|
Increase in inventory |
(317,472) |
(100,509) |
Origination of mortgage loans |
|
|
Sale of mortgage loans |
|
|
Decrease (increase) in restricted cash |
192 |
650 |
Increase (Decrease) in Other Operating Assets |
(115,728) |
(177,589) |
Increase in customer deposits |
10,717 |
9,291 |
(Decrease) increase in accounts payable and accrued expenses |
(9,867) |
(11,553) |
Increase (decrease) in income taxes payable |
|
|
Net cash used in operating activities |
(421,634) |
(276,849) |
Cash flow from investing activities: |
|
|
Purchase of property and equipment - net |
(5,123) |
(2,563) |
Purchase of marketable securities |
(25,938) |
|
Sale and redemption of marketable securities |
38,775 |
88,217 |
Investment in and advances to unconsolidated entities |
(2,047) |
(256) |
Return of investments in unconsolidated entities |
7,960 |
15,333 |
Investment in distressed loans and foreclosed real estate |
|
|
Return of investments in distressed loans and foreclosed real estate |
|
|
Acquisition of a business |
|
(144,746) |
Net cash used in investing activities |
13,627 |
(44,015) |
Cash flow from financing activities: |
|
|
Proceeds from loans payable |
|
|
Principal payments of loans payable |
(10,112) |
(12,520) |
Redemption of senior notes |
|
|
Proceeds from stock-based benefit plans |
|
|
Purchase of treasury stock |
|
|
Net cash used in financing activities |
(10,112) |
(12,520) |
Net decrease in cash and cash equivalents |
(418,119) |
(333,384) |
Cash and cash equivalents, beginning of period |
711,375 |
775,300 |
Cash and cash equivalents, end of period |
293,256 |
441,916 |
Non-Guarantor Subsidiaries [Member]
|
|
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
Net income (loss) |
3,168 |
1,689 |
Depreciation and amortization |
191 |
16 |
Stock-based compensation |
|
|
Income from unconsolidated entities |
(1,966) |
1,042 |
Distributions of earnings from unconsolidated entities |
1,723 |
|
Income from distressed loans and foreclosed real estate |
(3,011) |
(4,138) |
Deferred tax provision (benefit) |
|
|
Deferred tax valuation allowances |
|
|
Inventory impairments and write-offs |
|
|
Change in fair value of mortgage loans receivable and derivative instruments |
554 |
346 |
Gain on marketable securities |
|
|
Changes in operating assets and liabilities |
|
|
Increase in inventory |
(61,274) |
(7,959) |
Origination of mortgage loans |
(141,148) |
(120,662) |
Sale of mortgage loans |
176,830 |
146,895 |
Decrease (increase) in restricted cash |
119 |
(824) |
Increase (Decrease) in Other Operating Assets |
79,311 |
173,768 |
Increase in customer deposits |
1,342 |
(6,061) |
(Decrease) increase in accounts payable and accrued expenses |
6,934 |
(60,072) |
Increase (decrease) in income taxes payable |
|
|
Net cash used in operating activities |
62,773 |
124,040 |
Cash flow from investing activities: |
|
|
Purchase of property and equipment - net |
(268) |
(829) |
Purchase of marketable securities |
(81) |
|
Sale and redemption of marketable securities |
|
|
Investment in and advances to unconsolidated entities |
(5,567) |
(71,528) |
Return of investments in unconsolidated entities |
9,351 |
|
Investment in distressed loans and foreclosed real estate |
(16,252) |
(26,410) |
Return of investments in distressed loans and foreclosed real estate |
3,015 |
3,702 |
Acquisition of a business |
|
|
Net cash used in investing activities |
(9,802) |
(95,065) |
Cash flow from financing activities: |
|
|
Proceeds from loans payable |
244,830 |
199,139 |
Principal payments of loans payable |
(289,750) |
(225,376) |
Redemption of senior notes |
|
|
Proceeds from stock-based benefit plans |
|
|
Purchase of treasury stock |
|
|
Net cash used in financing activities |
(44,920) |
(26,237) |
Net decrease in cash and cash equivalents |
8,051 |
2,738 |
Cash and cash equivalents, beginning of period |
67,449 |
131,040 |
Cash and cash equivalents, end of period |
75,500 |
133,778 |
Eliminations [Member]
|
|
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
Net income (loss) |
(6,791) |
1,093 |
Depreciation and amortization |
(2,381) |
|
Stock-based compensation |
|
|
Income from unconsolidated entities |
|
|
Distributions of earnings from unconsolidated entities |
|
|
Income from distressed loans and foreclosed real estate |
|
|
Deferred tax provision (benefit) |
|
|
Deferred tax valuation allowances |
|
|
Inventory impairments and write-offs |
(31) |
|
Change in fair value of mortgage loans receivable and derivative instruments |
|
|
Gain on marketable securities |
|
|
Changes in operating assets and liabilities |
|
|
Increase in inventory |
31 |
|
Origination of mortgage loans |
|
|
Sale of mortgage loans |
|
|
Decrease (increase) in restricted cash |
|
|
Increase (Decrease) in Other Operating Assets |
11,776 |
(1,701) |
Increase in customer deposits |
|
|
(Decrease) increase in accounts payable and accrued expenses |
(2,604) |
608 |
Increase (decrease) in income taxes payable |
|
|
Net cash used in operating activities |
0 |
0 |
Cash flow from investing activities: |
|
|
Purchase of property and equipment - net |
|
|
Purchase of marketable securities |
|
|
Sale and redemption of marketable securities |
|
|
Investment in and advances to unconsolidated entities |
|
|
Return of investments in unconsolidated entities |
|
|
Investment in distressed loans and foreclosed real estate |
|
|
Return of investments in distressed loans and foreclosed real estate |
|
|
Acquisition of a business |
|
|
Net cash used in investing activities |
0 |
0 |
Cash flow from financing activities: |
|
|
Proceeds from loans payable |
|
|
Principal payments of loans payable |
|
|
Redemption of senior notes |
|
|
Proceeds from stock-based benefit plans |
|
|
Purchase of treasury stock |
|
|
Net cash used in financing activities |
0 |
0 |
Net decrease in cash and cash equivalents |
0 |
0 |
Cash and cash equivalents, beginning of period |
|
|
Cash and cash equivalents, end of period |
$ 0 |
$ 0 |